UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000028767
Receipt No. R000032920
Official scientific title of the study Evaluation of side-effects of dexmedetomidine during endoscopic submucosal dissection
Date of disclosure of the study information 2017/08/22
Last modified on 2018/09/02 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Evaluation of side-effects of dexmedetomidine during endoscopic submucosal dissection
Title of the study (Brief title) Side-effects of dexmedetomidine during ESD
Region
Japan

Condition
Condition neoplastic lesions of esophagus, stomach and colon
Classification by specialty
Gastroenterology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 Evaluation of hydration for side-effects of dexmedetomidine during endoscopic submucosal dissection
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Side-effects (hypotension, bradycardia, respiratory depression)
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control Active
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Hydration with maintenance fluid
Interventions/Control_2 only maintenance fluid
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
90 years-old >=
Gender Male and Female
Key inclusion criteria Patients who undergo ESD (esophagus, stomach and colon) with using DEX
Key exclusion criteria 1)uncontrollable diabetes
2)uncontrollable hypertension
3)uncontrollable heart disease
4)hypovolemic
5)severe or uncontroallable respiratory disease
6)acute alcoholoic addiction
Target sample size 120

Research contact person
Name of lead principal investigator Naohiko Akimoto
Organization Nippon Medical School Chiba-Hokuso Hospital
Division name Department of Gastroenterology
Address 1715 Kamagari, Inzai, Chiba, Japan
TEL 0476-99-1111
Email s03-004an@nms.ac.jp

Public contact
Name of contact person Naohiko Akimoto
Organization Nippon Medical School Chiba-Hokuso Hospital
Division name Department of Gastroenterology
Address 1715 Kamagari, Inzai, Chiba, Japan
TEL 0476-99-1111
Homepage URL
Email s03-004an@nms.ac.jp

Sponsor
Institute Nippon Medical School
Institute
Department

Funding Source
Organization Nippon Medical School
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2017 Year 08 Month 22 Day

Progress
Recruitment status Completed
Date of protocol fixation
2017 Year 08 Month 08 Day
Anticipated trial start date
2017 Year 08 Month 22 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2017 Year 08 Month 22 Day
Last modified on
2018 Year 09 Month 02 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000032920